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Benign hereditary chorea caused by mutations in the NK2 homeobox 1 gene (NKX2-1), 
shares clinical features with ataxic and dyskinetic cerebral palsy (CP), resulting in the 
possibility of misdiagnosis.  A father and his two children were considered to have ataxic CP 
until a possible diagnosis of benign familial chorea was made in the children in early teenage.  
The father’s neurological condition had not been appreciated prior to examination of the 
affected son. Whole exome sequencing of blood derived DNA and bioinformatics analysis 
were performed.  
A 7 bp deletion in exon 1 of NKX2-1, resulting in a frame shift and creation of a 
premature termination codon, was identified in all affected individuals.  Screening of 60 
unrelated individuals with a diagnosis of dyskinetic or ataxic CP did not identify NKX2-1 
mutations. BHC can be confused with ataxic and dyskinetic CP. Occasionally these children 





Cerebral palsy (CP) describes a group of permanent disorders of the development of 
movement and posture, that are attributed to non-progressive disturbances that occurred in 
the developing fetal or infant brain.[1]  The motor dysfunction of CP is divided into three 
categories: spastic, ataxic and dyskinetic.  Spastic CP is characterised by increased muscle 
tone, ataxic CP is characterised by low muscle tone and cerebellar features including 
intention tremor, poor balance and poor coordination.[2]  Dyskinetic CP is characterised by 
involuntary movements, either athetosis or dystonia, and mixed muscle tone.[1] 
Benign Hereditary Chorea (BHC) is an autosomal dominant movement disorder 
characterised by non-progressive or very slowly progressive chorea with normal cognitive 
function. Choreiform movements may involve the limbs, face, neck, trunk and tongue.    
While chorea is the characteristic movement disorder, atypical features including gait 
disturbance, dystonia, ataxia, intention tremor, dysarthria and pyramidal signs may 
accompany BHC.  In a minority of affected individuals, the disorder may involve the thyroid 
presenting as congenital hypothyroidism, and/or lung, with respiratory distress syndrome or 
recurrent lung infection.[3, 4] Benign Hereditary Chorea results from mutations of the NK2 
homeobox 1 gene (NKX2-1), located at chromosome 14q13.3, which encodes a transcription 
factor important for the development of the lung, thyroid and brain.[5]  NKX2-1 consists of 
three coding exons, which are transcribed into two major NKX2-1 mRNA isoforms encoding 
different proteins of 371 and 401 amino acids in length.[4]  Deletions, missense mutations 
and nonsense mutations have been described in NKX2-1 and result in haploinsufficiency.[6, 
7]  The gene is highly expressed in the fetal brain and is involved in neuronal migration and 
development of the basal ganglia.[8]  We report a father and his two children who were 
diagnosed with ataxic CP in early childhood.  The father’s neurological condition was not 
appreciated until examination of his son.  The clinical diagnosis was revised to BHC, with 
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identification of a pathogenic mutation in NKX2-1 by whole-exome sequencing of the family 
during a research study into the genetic basis of CP.  To determine other BHC cases with 
similar phenotypes, we sequenced NKX2-1 in 60 unrelated individuals diagnosed with ataxic, 
dyskinetic and/or athetoid CP. 
 
2. Clinical report 
2.1 The Family 
The affected family members are a father, his son and his daughter (II-1, III-2 and III-
3, in Figure 1) with a previously unreported mutation of the NKX2.1 gene.  The father and his 
wife are Caucasian, non-consanguineous and have an unaffected son. 
 
2.2 The affected father 
He was born at term after a normal pregnancy, labour and delivery but had delayed 
onset of respiration. There were no problems in the neonatal period. He walked late and is 
described as having had genu valgum, an awkward gait and a tendency to fall easily; 
coordination was generally poor through childhood.  He was an above average student at 
school and completed tertiary studies.  Neurological examination at the time his son was 
diagnosed revealed definite though mild ataxia; he was able to stand on one leg for 
approximately 10 seconds but tandem gait was ataxic.  He did not have nystagmus or chorea.  
When seen at 49 years of age he described mild dysarthria when tired, and mild functional 
difficulties due to his ataxia.  Walking was not usually a problem but he avoided running; 
when he ran, his legs “locked” and he overbalanced. He avoided carrying things in both 
hands, as this made him less stable. He found it difficult to use both hands simultaneously to 
perform separate tasks.  Examination revealed an inability to heel-toe walk and minor left 
intention tremor on finger-nose testing. 
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2.3 The affected son 
Following a normal pregnancy, he was born at 39 weeks gestation by caesarean 
delivery after failure of labour to progress with Apgar scores of 9 and 9 at one and five 
minutes, birth weight 2970 g (10th-50th percentile), birth length 51.5 cm (50th-90th percentile) 
and birth head circumference 34.0 cm (10th-50th percentile).  There was no respiratory distress 
or abnormalities   on newborn screening.  A paediatrician documented developmental delay 
with ataxia at 16 months of age and a diagnosis of ataxic CP was made.  He sat at 18 months, 
walked and had about 40 words at 20 months and used phrases by three years.  When seen by 
a neurologist at 20 months he had an unsteady gait, fell frequently and there were some 
choreiform movements.  At 24 months he had choreoathetoid movements and ataxia 
persisted.  He had speech therapy between two and three years.  A diagnosis of BHC was 
considered at 12 years of age.  At 15 years he had choreiform movements and no ataxia; the 
chorea was exacerbated by emotion.  Handwriting was poor and he ran awkwardly, fell 
frequently and had had a number of fractures.  Intelligence was above average, his speech 
was clear and he was a gifted swimmer in spite of his neurological disorder. 
 
2.4 The affected daughter 
Following a normal pregnancy, she was born at 40 weeks gestation by elective caesarean 
delivery with Apgar scores of 6 and 9 at one and five minutes, birth weight 3440 g (50th 
percentile), birth length 53 cm (90th percentile) and birth head circumference 34.0 cm (10th-
50th percentile).  There was mild respiratory distress attributed to meconium aspiration. 
Newborn screening was normal.  Motor milestones were delayed: she sat at 6-8 months, 
crawled at 12 months and walked at 17 months, with frequent falls but without the jerky 
movements seen in her brother.  Speech development was normal.  A neurologist assessed 
her at 20 months, at which time she was considered to have an ataxic gait; upper limb 
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movement was normal.  At 3.5 years, speech and cognitive function were normal and there 
were mild choreoathetoid movements and an ataxic gait.  At 11 years, there was chorea 
affecting her face, trunk, arms and legs; there was no ataxia.  She was a gifted student, with 
good handwriting. 
 
2.5 Other cases of dyskinetic or ataxic CP 
We selected 60 unrelated Caucasian individuals with a diagnosis of dyskinetic or ataxic CP 
from the Australian CP Research Study[9] – 29 (48%) had ataxic CP, 16 (27%) had 
dyskinetic athetoid CP, 10 (17%) had dyskinetic dystonic CP and 5 (8%) had dyskinetic CP 
without known subtype.  There were no reported family histories of CP.   
Research ethics approval was obtained from Women’s and Children’s Health 
Network Human Research Ethics Committee (Approval No. REC 1946/4/10) and signed 




3.1 DNA isolation  
For each individual in the three generation pedigree DNA was isolated from whole blood 
using a QIamp DNA Midi kit (Qiagen, Stanford, CA) following the manufacturer’s 
instructions.  DNA had previously been extracted from buccal swabs obtained from a 







3.2 Whole-exome sequencing and analysis  
Initially whole-exome sequencing was performed for the three affected individuals (II-1, III-2 
and III-3) and the two unaffected individuals in the second and third generation (II-2 and III-
1).  Following Nimblegen Exome sequence capture, enriched genomic DNA was massively 
parallel sequenced on the Illumina HiSeq 2000 platform (Macrogen), which returned on 
average 48.3 million 100 bp pair end reads per individual.  These reads were quality trimmed 
using the FASTX toolkit.  Quality reads were mapped to the hg19 build of the human 
genome by using Burrows-Wheeler Alignment tool. Samtools were used to generate BAM 
files.  Sequence variants were realigned, recalibrated and reported with Genome Analysis 
ToolKit and categorised with Annovar.  We filtered the variants based on dbSNP132 and 
1000 genomes, exonic/splice sites, nonsynonymous and then further filtered for inheritance 
models including, autosomal dominant, autosomal recessive both homozygous and 
compound heterozygous and de novo variants. 
 
3.3 Sanger sequencing  
To confirm the mutation in the family unique primers incorporating the 7 bp deletion were 
designed using Primer3 (v.0.4.0), (forward 5’-CTGTTCCTCATGGTGTCCTGGT-3’, 
reverse 5’-GAATCATGTCGATGAGT CCAAAG-3’).  For the 60 unrelated individuals 
diagnosed with dyskinetic or ataxic CP, the entire protein coding region of the NKX2-1 gene 
was amplified in four fragments.  Four primer pairs were designed using Primer3 (v.0.4.0).  
Primer set 1: (forward: 5’-CAGTCGATCCCCTACTCAGC-3’, reverse: 5’GTAACAGAGG 
AGGAGAGATGGT TG-3’), primer set 2: (forward: 5’-AATGCTTTGGGTCTCGTCTCT-
3’, reverse: 5’-CACT TTCTTGTAGCTTTCCTCCAG-3’), primer set 3: (forward: 5’-
TACGTGTACATCCAA CAAGATCG-3’, reverse: 5’-TACCAAGTCCCTGTTCTTGGAC-
3’), primer set 4: (forward: 5’-TCGAAAGAGGGAACTGAGACTGAG-3’, reverse: 5’-
9 
 
GCCAGGTTGTTAAGAAAA GTCGA -3’).  Sanger sequencing was performed using 
BigDye terminator chemistry 3.1 (ABI) and sequenced using an ABI prism 3700 genetic 
analyser (Applied Biosystems, Foster City, CA, USA).  Sequencing data was analysed using 
DNASTAR Lasergene 10 Seqman Pro (DNASTAR, Inc. Madison, WI, USA). 
 
4. Results 
Analysis of whole-exome sequencing data for all individuals in generations II and III 
identified a 7 bp deletion within exon 1 of NKX2-1 in all three affected individuals.  Both 
unaffected individuals do not carry this deletion (Figures 1).  Results were confirmed by 
Sanger sequencing (Figure 2A).  Neither of the father’s unaffected parents had the deletion, 
suggesting that it occurred de novo in the father (II-1) and was transmitted in an autosomal 
dominant manner to his affected children (III-2 and III-3).  The deletion in NKX2-1 
(NM_003317: exon1: c.84_90del) is predicted to result in a premature termination codon 
(PTC) and a truncated NKX2-1 protein (p.M59fs*39) (Figure 2B).  It is plausible that the 
PTC containing NKX2-1 mRNA is degraded by non-sense mediated mRNA decay (NMD) 
resulting in the absence of one copy of the NKX2-1 protein. The effect of NMD on the 
c.84_90del NKX2-1 mRNA could not be tested as NKX2-1 is not expressed in routinely 
available tissue (i.e. blood, skin or saliva).  The c.84_90del mutation is predicted to affect 
both NKX2-1 mRNA isoforms. 
Sanger sequencing of 60 unrelated participants from the Australian CP Research 








We describe two siblings who were considered to have ataxic CP in early childhood. Their 
father had a mild cerebellar syndrome, not appreciated at the time of their presentation.  
Diagnosis was based on the presence of delayed motor milestones and a non-progressive 
movement disorder, ataxic in nature, associated with gait disturbance and frequent falls.  As 
the children grew older, choreoathetosis became the predominant neurological feature, 
although ataxia persisted through the first decade.  It was recognised that the diagnosis was 
BHC when reviewed by a neurologists in their early teenage years. Coincidentally, a 
mutation was identified by whole-exome sequencing in NKX2-1 at around the same time 
because the family was participating, in the Australian CP Research Study.  The affected 
individuals in this family shared a 7 bp deletion of exon 1 of NKX2-1 resulting in a frame 
shift, with creation of a premature termination codon.  This is predicted to cause 
haploinsufficiency, either as a result of a non-functional, truncated NKX2-1 protein or 50% 
reduction of the protein levels due to NMD degradation of the premature termination codon 
containing NKX2-1 mRNA allele.[6, 7]  
While BHC, with its characteristic choreiform movements, would not commonly be 
confused with ataxic CP, similar cases have been reported[11, 12].  Doyle et al.12 reported 
siblings with an NKX2-1 mutation who had congenital hypothyroidism, global developmental 
delay and later ataxia, choreoathetosis and dysarthria.  Their mother had been diagnosed with 
CP during childhood; she was described as having ataxia as an adult. Carre et al[12] 
described a child with an NKX2-1 mutation who had congenital hypothyroidism and 
respiratory distress syndrome and in whom ataxic movements and psychomotor delay 
presented in the first year.   
BHC may be difficult to diagnose in early childhood before the characteristic 
choreiform movements are apparent, especially in the absence of a family history of the 
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disorder and when the child has an atypical movement disorder at the time of first diagnostic 
evaluation.  It is possible that there are a small number of BHC cases among patients 
diagnosed to have dyskinetic or ataxic CP.  However, we did not find any individuals with an 
NKX2-1 mutation among 60 unrelated cases of dyskinetic or ataxic CP. 
The family reported here exemplifies the problem that clinicians face in 
distinguishing between CP and genetic neurological disorders that include the motor 
components of CP among their features, especially when the diagnostic evaluation is being 
done early in life.  Other examples are disorders caused by mutations in GAD1,[13, 14] 
KANK1,[15] and the adaptor protein complex-4 (AP4E1, AP4M1, Ap4B1, and AP4S1).[16-
19] 
  This study highlights the importance of genetic investigation of individuals with CP, 
because a proportion, yet to be defined, will have an underlying genetic disorder, with 




Our thanks to Chloe Shard of the Neurogenetics department, at the Women’s and 
Children’s Hospital, Adelaide for help with sequencing the unrelated individuals, and Drs 
Raman Sharma and Mark Corbett at the Neurogenetics department at the University of 
Adelaide for help with the images.  We thank the family involved in this project for their 
support of CP research. 
This study was funded by the Australian National Health and Medical Research 
Council (Grant No. 1019928), CP Alliance Research Foundation, and the Women’s and 
Children’s Hospital Foundation, Adelaide. 
 
Conflicts of interest 





Figure 1: Three generation pedigree with de novo mutation in II-1 and subsequent autosomal 
dominant transmission in III-2 and III-3.  All family individuals were sequenced with Sanger 
sequencing.  *Represents individuals carrying the mutation, remaining family members were 




Figure 2: (A) Fragments of sequence chromatograms from an affected individual 
(heterozygous mutation) and an unaffected individual (normal homozygous) from 5’ – 3’ and 
corresponding amino acid sequences. (B) Comparison of amino acid sequences of wildtype 
and mutant NKX2-1 proteins.  The change was at position 59 introducing a premature 
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